NuVasive insider sells 4k+ shares: 5 key points

NuVasive insider Matthew Link sold more than 4,000 shares of the company’s stock, according to a Ticker Report article.

Advertisement

Here are five things to know:

 

•    Mr. Link sold 4,078 shares
•    Average share price was $45.77
•    Total transaction was valued at $186,650
•    Mr. Link now directly owns 67,655 shares
•    His shares are valued at approximately $3.09 million

 

NuVasive has a one-year low of $31.35 and a one-year high of $51.23. The company’s shares have appreciated by 0.89 percent over the last week.

More articles on devices:

Amedica brings on with PCG Advisory as agency of record
OrthoWorx commits $475k on workforce development — 6 initiatives
Mesoblast gets patent for mesenchymal precursor cell technology — 7 thing to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.